Free Trial

Atai Life Sciences (ATAI) Competitors

Atai Life Sciences logo
$2.02 +0.11 (+5.76%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$2.02 +0.00 (+0.05%)
As of 05/22/2025 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ATAI vs. BGM, AUPH, WVE, GYRE, MLYS, PAHC, COLL, SNDX, ELVN, and RCUS

Should you be buying Atai Life Sciences stock or one of its competitors? The main competitors of Atai Life Sciences include Qilian International Holding Group (BGM), Aurinia Pharmaceuticals (AUPH), Wave Life Sciences (WVE), Gyre Therapeutics (GYRE), Mineralys Therapeutics (MLYS), Phibro Animal Health (PAHC), Collegium Pharmaceutical (COLL), Syndax Pharmaceuticals (SNDX), Enliven Therapeutics (ELVN), and Arcus Biosciences (RCUS). These companies are all part of the "pharmaceutical products" industry.

Atai Life Sciences vs.

Qilian International Holding Group (NASDAQ:BGM) and Atai Life Sciences (NASDAQ:ATAI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations, profitability and community ranking.

28.4% of Atai Life Sciences shares are owned by institutional investors. 58.7% of Qilian International Holding Group shares are owned by insiders. Comparatively, 31.2% of Atai Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Qilian International Holding Group has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Comparatively, Atai Life Sciences has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500.

Atai Life Sciences received 336 more outperform votes than Qilian International Holding Group when rated by MarketBeat users.

CompanyUnderperformOutperform
Qilian International Holding GroupN/AN/A
Atai Life SciencesOutperform Votes
336
66.53%
Underperform Votes
169
33.47%

In the previous week, Atai Life Sciences had 7 more articles in the media than Qilian International Holding Group. MarketBeat recorded 7 mentions for Atai Life Sciences and 0 mentions for Qilian International Holding Group. Atai Life Sciences' average media sentiment score of 0.64 beat Qilian International Holding Group's score of 0.00 indicating that Atai Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Qilian International Holding Group Neutral
Atai Life Sciences Positive

Qilian International Holding Group's return on equity of 0.00% beat Atai Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Qilian International Holding GroupN/A N/A N/A
Atai Life Sciences N/A -65.75%-52.71%

Qilian International Holding Group has higher revenue and earnings than Atai Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Qilian International Holding Group$25.10M48.38-$1.44MN/AN/A
Atai Life Sciences$1.86M219.91-$40.22M-$0.91-2.25

Atai Life Sciences has a consensus target price of $10.50, suggesting a potential upside of 413.45%. Given Atai Life Sciences' stronger consensus rating and higher probable upside, analysts plainly believe Atai Life Sciences is more favorable than Qilian International Holding Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Qilian International Holding Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Atai Life Sciences
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

Summary

Atai Life Sciences beats Qilian International Holding Group on 9 of the 15 factors compared between the two stocks.

Get Atai Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATAI vs. The Competition

MetricAtai Life SciencesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$409.69M$6.51B$5.35B$8.44B
Dividend YieldN/A2.64%5.21%4.11%
P/E Ratio-2.529.1526.9119.77
Price / Sales219.91259.30390.06119.10
Price / CashN/A65.8538.2534.62
Price / Book1.396.476.794.52
Net Income-$40.22M$144.21M$3.23B$248.23M
7 Day Performance25.46%2.64%1.99%0.77%
1 Month Performance39.12%4.80%11.45%13.45%
1 Year Performance22.46%-2.52%17.35%7.67%

Atai Life Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATAI
Atai Life Sciences
2.3001 of 5 stars
$2.02
+5.8%
$10.50
+419.8%
+21.0%$404.68M$1.86M-2.4980News Coverage
Analyst Forecast
Analyst Revision
BGM
Qilian International Holding Group
N/A$11.54
+4.7%
N/AN/A$1.12B$25.10M0.00298Positive News
Gap Up
AUPH
Aurinia Pharmaceuticals
2.4142 of 5 stars
$8.14
+1.8%
$11.50
+41.3%
+49.5%$1.12B$235.13M-54.40300
WVE
Wave Life Sciences
4.3742 of 5 stars
$6.69
+1.4%
$21.17
+216.6%
-5.4%$1.03B$108.30M-6.02240Positive News
GYRE
Gyre Therapeutics
0.3745 of 5 stars
$11.00
+15.4%
N/A-17.2%$1.02B$105.76M544.5040News Coverage
MLYS
Mineralys Therapeutics
2.884 of 5 stars
$15.38
+5.0%
$33.00
+114.5%
+30.4%$992.93MN/A-4.2028Analyst Upgrade
Gap Down
PAHC
Phibro Animal Health
3.52 of 5 stars
$24.51
+9.1%
$20.00
-18.4%
+25.0%$990.30M$1.11B50.941,860Positive News
COLL
Collegium Pharmaceutical
4.0425 of 5 stars
$29.96
+3.7%
$43.80
+46.2%
-15.7%$961.71M$631.45M12.90210Positive News
SNDX
Syndax Pharmaceuticals
3.8219 of 5 stars
$11.08
+3.5%
$35.91
+224.2%
-47.9%$954.69M$43.72M-3.06110Positive News
ELVN
Enliven Therapeutics
2.4734 of 5 stars
$19.34
+5.0%
$40.33
+108.5%
-26.7%$949.13MN/A-10.1850News Coverage
Analyst Revision
Gap Up
RCUS
Arcus Biosciences
3.6538 of 5 stars
$8.92
+7.8%
$25.67
+187.6%
-47.6%$939.73M$141M-2.82500Gap Up
High Trading Volume

Related Companies and Tools


This page (NASDAQ:ATAI) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners